Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway. 2009

Julie Lodewick, and Isabelle Lamsoul, and Angela Polania, and Sylvie Lebrun, and Arsène Burny, and Lee Ratner, and Françoise Bex
Institute for Microbiological Research J-M Wiame and Laboratory of Microbiology, Université Libre de Bruxelles, 1, Avenue Emile Gryson, B-1070 Brussels, Belgium.

The oncogenic potential of the HTLV-1 Tax protein involves activation of the NF-kappaB pathway, which depends on Tax phosphorylation, ubiquitination and sumoylation. We demonstrate that the nuclei of Tax-expressing cells, including HTLV-1 transformed T-lymphocytes, contain a pool of Tax molecules acetylated on lysine residue at amino acid position 346 by the transcriptional coactivator p300. Phosphorylation of Tax on serine residues 300/301 was a prerequisite for Tax localization in the nucleus and correlated with its subsequent acetylation by p300, whereas sumoylation, resulting in the formation of Tax nuclear bodies in which p300 was recruited, favored Tax acetylation. Overexpression of p300 markedly increased Tax acetylation and the ability of a wild type HTLV-1 provirus, but not of a mutant provirus carrying an acetylation deficient Tax gene, to activate gene expression from an integrated NF-kappaB-controlled promoter. Thus, Tax acetylation favors NF-kappaB activation and might play an important role in HTLV-1-induced cell transformation.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D016356 Gene Products, tax Transcriptional trans-acting proteins of the promoter elements found in the long terminal repeats (LTR) of HUMAN T-LYMPHOTROPIC VIRUS 1 and HUMAN T-LYMPHOTROPIC VIRUS 2. The tax (trans-activator x; x is undefined) proteins act by binding to enhancer elements in the LTR. Trans-Activator Protein p40(tax),Trans-Activator Protein p40(x),p40(tax),tax Gene Products,tax Protein,Gene Product, tax,Trans-Activator Protein p40(lor),Trans-Activator Protein p40x,Trans-Activator Protein pX,Transactivator Protein p40(x),Transactivator p40(tax),Transforming Antigen p40x,p40 tax,Antigen p40x, Transforming,Trans Activator Protein p40x,Trans Activator Protein pX,p40x, Trans-Activator Protein,p40x, Transforming Antigen,pX, Trans-Activator Protein,tax Gene Product
D050881 E1A-Associated p300 Protein A member of the p300-CBP transcription factors that was originally identified as a binding partner for ADENOVIRUS E1A PROTEINS. p300 E1A-Associated Coactivator,E1A Associated p300 Protein,E1A-Associated Coactivator, p300,p300 E1A Associated Coactivator,p300 Protein, E1A-Associated

Related Publications

Julie Lodewick, and Isabelle Lamsoul, and Angela Polania, and Sylvie Lebrun, and Arsène Burny, and Lee Ratner, and Françoise Bex
October 2015, The Journal of biological chemistry,
Julie Lodewick, and Isabelle Lamsoul, and Angela Polania, and Sylvie Lebrun, and Arsène Burny, and Lee Ratner, and Françoise Bex
December 2007, Journal of virology,
Julie Lodewick, and Isabelle Lamsoul, and Angela Polania, and Sylvie Lebrun, and Arsène Burny, and Lee Ratner, and Françoise Bex
August 1998, Journal of virology,
Julie Lodewick, and Isabelle Lamsoul, and Angela Polania, and Sylvie Lebrun, and Arsène Burny, and Lee Ratner, and Françoise Bex
July 2005, International journal of cancer,
Julie Lodewick, and Isabelle Lamsoul, and Angela Polania, and Sylvie Lebrun, and Arsène Burny, and Lee Ratner, and Françoise Bex
February 2006, Genes to cells : devoted to molecular & cellular mechanisms,
Julie Lodewick, and Isabelle Lamsoul, and Angela Polania, and Sylvie Lebrun, and Arsène Burny, and Lee Ratner, and Françoise Bex
August 1998, Journal of virology,
Julie Lodewick, and Isabelle Lamsoul, and Angela Polania, and Sylvie Lebrun, and Arsène Burny, and Lee Ratner, and Françoise Bex
July 2002, Molecular and cellular biology,
Julie Lodewick, and Isabelle Lamsoul, and Angela Polania, and Sylvie Lebrun, and Arsène Burny, and Lee Ratner, and Françoise Bex
February 2007, Blood,
Julie Lodewick, and Isabelle Lamsoul, and Angela Polania, and Sylvie Lebrun, and Arsène Burny, and Lee Ratner, and Françoise Bex
June 1999, The Journal of biological chemistry,
Julie Lodewick, and Isabelle Lamsoul, and Angela Polania, and Sylvie Lebrun, and Arsène Burny, and Lee Ratner, and Françoise Bex
September 2013, Virology,
Copied contents to your clipboard!